Ryvyl (NASDAQ:RVYL – Get Free Report) will be releasing its earnings data after the market closes on Monday, August 14th. Analysts expect Ryvyl to post earnings of ($0.07) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.
Ryvyl (NASDAQ:RVYL – Get Free Report) last issued its earnings results on Thursday, May 25th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.07). Ryvyl had a negative return on equity of 225.08% and a negative net margin of 72.87%. The firm had revenue of $11.29 million during the quarter, compared to analysts’ expectations of $12.30 million. During the same period last year, the firm posted ($0.13) earnings per share.
Ryvyl Stock Down 12.1 %
RVYL opened at $1.09 on Friday. The firm has a 50 day moving average price of $1.04 and a 200-day moving average price of $0.70. Ryvyl has a twelve month low of $0.27 and a twelve month high of $2.86. The stock has a market capitalization of $55.96 million, a price-to-earnings ratio of -1.98 and a beta of 3.20.
Institutional Investors Weigh In On Ryvyl
About Ryvyl
Ryvyl Inc, a technology company, engages in the development, marketing, and sale of blockchain-based payment solutions. The company's blockchain-based systems facilitate, record, and store a volume of tokenized assets representing cash or data on a blockchain-based ledger. Its products include QuickCard Payment System, a physical and virtual payment card processing management system, including software that facilitates on and off ramp e-wallet management; point of sale solutions comprising software and hardware; and Coyni, a digital currency platform that is backed on a 1:1 ratio to the U.S.
Read More
- Five stocks we like better than Ryvyl
- The Significance of Brokerage Rankings in Stock Selection
- Investing in Coffee: 3 Great Strategies to Consider
- Understanding and Trading Breakout Stocks
- 5 Best Stocks to Buy in a Bear Market
- Retail Stocks Investing, Explained
- 3 Pharmaceutical Stocks to Buy and Hold for the Long Haul
Receive News & Ratings for Ryvyl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryvyl and related companies with MarketBeat.com's FREE daily email newsletter.